Print Page

给 医 护 专 业 人 员 的 信
 
Isotretinoin (Roaccutane): rare reports of erectile dysfunction and decreased libido (Letter to Healthcare Professionals) (English Only)
 
 
 
附件:
  1. Isotretinoin (Roaccutane): rare reports of erectile dysfunction and decreased libido  
Related Information:
The United Kingdom: Isotretinoin – changes to prescribing guidance and additiona... 上载于 2026-01-23
中国：国家药监局关于修订异维A酸软胶囊说明书的公告（2026年第2号） 上载于 2026-01-07
Australia: New safety warnings for isotretinoin (Roaccutane) (English only) 上载于 2025-04-08
Canada: Summary Safety Review: Isotretinoin: Assessing the potential risk of sex... 上载于 2024-07-26
Singapore: HSA: Isotretinoin and risk of psychiatric disorders and sexual dysfun... 上载于 2023-12-16
The United Kingdom: Isotretinoin (Roaccutane▼): introduction of new safety measu... 上载于 2023-11-01
The United Kingdom: Isotretinoin (Roaccutane▼): new safety measures to be introd... 上载于 2023-04-27
Isotretinoin (Roaccutane▼): new safety measures to be introduced in the coming m... 上载于 2023-04-27
The United Kingdom: Isotretinoin: an expert review of suspected psychiatric and ... 上载于 2020-11-11
The United Kingdom: Isotretinoin (Roaccutane▼): reminder of important risks and ... 上载于 2020-08-27
英国：异维A酸(Roaccutane)：勃起功能障碍及性欲减少的罕有报告 上载于 2017-10-27
加拿大：加拿大卫生局强调服用粉刺药物异维A酸期间预防怀孕的重要性，以避免出生缺陷 上载于 2016-09-08
 
back